These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 34240451

  • 1. Efficacy and safety of oral sirolimus for high-flow vascular malformations in real clinical practice.
    Durán-Romero AJ, Hernández-Rodríguez JC, Ortiz-Álvarez J, Domínguez-Cruz JJ, Monserrat-García MT, Conejo-Mir Sánchez J, Bernabeu-Wittel J.
    Clin Exp Dermatol; 2022 Jan; 47(1):57-62. PubMed ID: 34240451
    [Abstract] [Full Text] [Related]

  • 2. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J, Seront E, Duez S, Dupont S, Van Damme A, Schmitz S, Hoyoux C, Chopinet C, Clapuyt P, Hammer F, Vikkula M, Boon LM.
    Orphanet J Rare Dis; 2018 Oct 29; 13(1):191. PubMed ID: 30373605
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
    Freixo C, Ferreira V, Martins J, Almeida R, Caldeira D, Rosa M, Costa J, Ferreira J.
    J Vasc Surg; 2020 Jan 29; 71(1):318-327. PubMed ID: 31676179
    [Abstract] [Full Text] [Related]

  • 4. Single Center Experience of Sirolimus Therapy in Head and Neck Low-flow Vascular Malformations.
    Pang C, Evans N, Jethwa P, Papadopoulou A, Khalifa M, Tsui J, Hamilton G, Lim CS, Brookes J.
    Vasc Endovascular Surg; 2021 Jul 29; 55(5):482-490. PubMed ID: 33878964
    [Abstract] [Full Text] [Related]

  • 5. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
    Maruani A, Boccara O, Bessis D, Guibaud L, Vabres P, Mazereeuw-Hautier J, Barbarot S, Chiaverini C, Blaise S, Droitcourt C, Mallet S, Martin L, Lorette G, Woillard JB, Jonville-Bera AP, Rollin J, Gruel Y, Herbreteau D, Goga D, le Touze A, Leducq S, Gissot V, Morel B, Tavernier E, Giraudeau B, Groupe de Recherche de la Societé Française de Dermatologie Pédiatrique.
    Trials; 2018 Jun 27; 19(1):340. PubMed ID: 29945674
    [Abstract] [Full Text] [Related]

  • 6. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
    Gómez Sánchez A, Redondo Sedano JV, Pérez Alonso V, Martí Carrera ME, Baro Fernández M, Palencia Pérez SI, Gallego Herrero MC, Gómez Fraile A, Delgado Muñoz MD.
    Cir Pediatr; 2020 Oct 01; 33(4):183-187. PubMed ID: 33016658
    [Abstract] [Full Text] [Related]

  • 7. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A, Tavernier E, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, Guibaud L, Vabres P, Carmignac V, Mallet S, Barbarot S, Chiaverini C, Droitcourt C, Bursztejn AC, Lengellé C, Woillard JB, Herbreteau D, Le Touze A, Joly A, Léauté-Labrèze C, Powell J, Bourgoin H, Gissot V, Giraudeau B, Morel B.
    JAMA Dermatol; 2021 Nov 01; 157(11):1289-1298. PubMed ID: 34524406
    [Abstract] [Full Text] [Related]

  • 8. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P, Miguel M, Díaz M, Cabrera M, López Gutiérrez JC.
    Lymphat Res Biol; 2019 Oct 01; 17(5):504-511. PubMed ID: 30985248
    [Abstract] [Full Text] [Related]

  • 9. Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.
    Sandbank S, Molho-Pessach V, Farkas A, Barzilai A, Greenberger S.
    Acta Derm Venereol; 2019 Oct 01; 99(11):990-996. PubMed ID: 31304557
    [Abstract] [Full Text] [Related]

  • 10. Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations.
    Yu L, Xu Z, Wei L, Zhang B, Qiu L, Ma L, Li L.
    Paediatr Drugs; 2024 May 01; 26(3):309-317. PubMed ID: 38280106
    [Abstract] [Full Text] [Related]

  • 11. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P, Dore M, Cerezo VN, Cervantes M, Sánchez AV, Ferrero MM, González MD, Lopez-Gutierrez JC.
    Eur J Pediatr Surg; 2017 Feb 01; 27(1):86-90. PubMed ID: 27723921
    [Abstract] [Full Text] [Related]

  • 12. Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus.
    Harbers VEM, Rongen GAPJM, van der Vleuten CJM, Verhoeven BH, de Laat PCJ, van der Horst CMAM, Klein WM, Schultze Kool LJ, Loo DMWMT.
    Adv Ther; 2021 Jun 01; 38(6):3465-3482. PubMed ID: 34003452
    [Abstract] [Full Text] [Related]

  • 13. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
    Dodds M, Tollefson M, Castelo-Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S.
    Pediatr Dermatol; 2020 Mar 01; 37(2):272-277. PubMed ID: 31957126
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.
    Adams DM, Trenor CC, Hammill AM, Vinks AA, Patel MN, Chaudry G, Wentzel MS, Mobberley-Schuman PS, Campbell LM, Brookbank C, Gupta A, Chute C, Eile J, McKenna J, Merrow AC, Fei L, Hornung L, Seid M, Dasgupta AR, Dickie BH, Elluru RG, Lucky AW, Weiss B, Azizkhan RG.
    Pediatrics; 2016 Feb 01; 137(2):e20153257. PubMed ID: 26783326
    [Abstract] [Full Text] [Related]

  • 15. Sirolimus for the treatment of children with various complicated vascular anomalies.
    Lackner H, Karastaneva A, Schwinger W, Benesch M, Sovinz P, Seidel M, Sperl D, Lanz S, Haxhija E, Reiterer F, Sorantin E, Urban CE.
    Eur J Pediatr; 2015 Dec 01; 174(12):1579-84. PubMed ID: 26040705
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of sirolimus in the treatment of vascular malformations: A protocol for systematic review and meta-analysis.
    Dong J, Han D, Wang D, Lu H, Wang X.
    Medicine (Baltimore); 2020 Oct 02; 99(40):e22596. PubMed ID: 33019479
    [Abstract] [Full Text] [Related]

  • 17. Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review.
    Saibene AM, Rosso C, Felisati G, Pignataro L, Schindler A, Ghilardi G, Colletti G, Gaffuri M, Mozzanica F.
    Eur Arch Otorhinolaryngol; 2023 Aug 02; 280(8):3529-3540. PubMed ID: 37115326
    [Abstract] [Full Text] [Related]

  • 18. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M, Nozawa A, Yasue S, Endo S, Asada R, Hashimoto H, Fukao T.
    Orphanet J Rare Dis; 2019 Jun 13; 14(1):141. PubMed ID: 31196128
    [Abstract] [Full Text] [Related]

  • 19. Treatment with oral or topical sirolimus in complex vascular anomalies in pediatrics. Experience in a third-level hospital.
    Fernández Oliveira C, Martínez Roca C, Gómez Tellado M, Salvador Garrido MP, Outeda Macías M, Martín Herranz I.
    Cir Pediatr; 2023 Apr 01; 36(2):60-66. PubMed ID: 37093114
    [Abstract] [Full Text] [Related]

  • 20. Single-center experience with sirolimus therapy for vascular malformations.
    Yesil S, Tanyildiz HG, Bozkurt C, Cakmakci E, Sahin G.
    Pediatr Hematol Oncol; 2016 Apr 01; 33(3):219-25. PubMed ID: 27128161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.